Most edited pathways

Showing below up to 50 results starting with #851.

View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)

851. Homo sapiens:Factors involved in megakaryocyte development and platelet production ‎(23 revisions)
852. Homo sapiens:Gastrin-CREB signaling via PKC and MAPK ‎(23 revisions)
853. Homo sapiens:Intrinsic Pathway for Apoptosis ‎(23 revisions)
854. Homo sapiens:Signaling by insulin receptor ‎(23 revisions)
855. Homo sapiens:TCR signaling ‎(23 revisions)
856. Homo sapiens:ATF4 activates genes in response to endoplasmic reticulum stress ‎(23 revisions)
857. Saccharomyces cerevisiae:Pantothenate and coenzyme A biosynthesis ‎(23 revisions)
858. Homo sapiens:Progeria-associated lipodystrophy ‎(23 revisions)
859. Arabidopsis thaliana:AtMetExpress overview ‎(23 revisions)
860. Mus musculus:Translation factors ‎(23 revisions)
861. Saccharomyces cerevisiae:De novo biosynthesis of purine nucleotides ‎(23 revisions)
862. Homo sapiens:DNA Damage Bypass ‎(23 revisions)
863. Homo sapiens:Neurotoxicity of clostridium toxins ‎(23 revisions)
864. Homo sapiens:Mitotic G2-G2/M phases ‎(23 revisions)
865. Homo sapiens:Processing of Capped Intronless Pre-mRNA ‎(23 revisions)
866. Homo sapiens:DDX58/IFIH1-mediated induction of interferon-alpha/beta ‎(23 revisions)
867. Homo sapiens:Telomere Maintenance ‎(23 revisions)
868. Homo sapiens:Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling ‎(23 revisions)
869. Rattus norvegicus:Regulation of actin cytoskeleton ‎(23 revisions)
870. Rattus norvegicus:Acetylcholine synthesis ‎(23 revisions)
871. Mus musculus:Retinol metabolism ‎(23 revisions)
872. Homo sapiens:JAK/STAT signaling and ARTD family members ‎(23 revisions)
873. Homo sapiens:Warburg effect modulated by deubiquitinating enzymes and their substrates ‎(23 revisions)
874. Homo sapiens:10q11.21q11.23 copy number variation syndrome ‎(23 revisions)
875. Homo sapiens:Interferon alpha/beta signaling ‎(23 revisions)
876. Homo sapiens:Regulation of cholesterol biosynthesis by SREBP (SREBF) ‎(23 revisions)
877. Mus musculus:ACE inhibitor pathway ‎(23 revisions)
878. Homo sapiens:Neurotransmitter release cycle ‎(23 revisions)
879. Caenorhabditis elegans:TOR signaling ‎(23 revisions)
880. Homo sapiens:Vitamin D in inflammatory diseases ‎(23 revisions)
881. Homo sapiens:FTO obesity variant mechanism ‎(23 revisions)
882. Homo sapiens:Effects of PIP2 hydrolysis ‎(23 revisions)
883. Homo sapiens:Interferon gamma signaling ‎(23 revisions)
884. Homo sapiens:Semaphorin interactions ‎(23 revisions)
885. Homo sapiens:Signaling by ROBO receptors ‎(23 revisions)
886. Oryza sativa:Momilactone biosynthesis ‎(23 revisions)
887. Mus musculus:PPAR signaling pathway ‎(23 revisions)
888. Rattus norvegicus:Myometrial relaxation and contraction pathways ‎(23 revisions)
889. Saccharomyces cerevisiae:NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde ‎(23 revisions)
890. Homo sapiens:Albuterol and budesonide therapy for asthma ‎(22 revisions)
891. Homo sapiens:exRNA mechanism of action and biogenesis ‎(22 revisions)
892. Homo sapiens:Uterine natural killer cells and progesterone, estrogen, and chorionic gonadotropin ‎(22 revisions)
893. Homo sapiens:Cell lineage map for neuronal differentiation ‎(22 revisions)
894. Homo sapiens:Meiotic synapsis ‎(22 revisions)
895. Rattus norvegicus:Urea cycle and metabolism of amino groups ‎(22 revisions)
896. Homo sapiens:MyD88 dependent cascade initiated on endosome ‎(22 revisions)
897. Saccharomyces cerevisiae:Phospholipid biosynthesis ‎(22 revisions)
898. Zea mays:Vitamin B7 (biotin) biosynthesis pathway ‎(22 revisions)
899. Homo sapiens:Neuroinflammation and glutamatergic signaling ‎(22 revisions)
900. Homo sapiens:SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation ‎(22 revisions)

View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)